Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
8.13
Dollar change
+0.13
Percentage change
1.63
%
Index- P/E- EPS (ttm)-12.40 Insider Own28.46% Shs Outstand20.84M Perf Week9.57%
Market Cap169.43M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float14.91M Perf Month24.12%
Income-16.03M PEG- EPS next Q- Inst Own0.06% Short Float0.06% Perf Quarter14.83%
Sales0.24M P/S705.96 EPS this Y- Inst Trans- Short Ratio0.09 Perf Half Y-33.46%
Book/sh27.23 P/B0.30 EPS next Y- ROA-38.86% Short Interest0.01M Perf Year-18.37%
Cash/sh0.94 P/C8.65 EPS next 5Y- ROE-41.49% 52W Range5.25 - 17.40 Perf YTD9.86%
Dividend Est.- P/FCF- EPS past 5Y- ROI-56.08% 52W High-53.28% Beta0.90
Dividend TTM- Quick Ratio10.16 Sales past 5Y1565.19% Gross Margin- 52W Low54.74% ATR (14)0.61
Dividend Ex-Date- Current Ratio10.16 EPS Y/Y TTM-89.45% Oper. Margin-6610.71% RSI (14)63.31 Volatility6.54% 8.26%
Employees15 Debt/Eq0.01 Sales Y/Y TTM-7.74% Profit Margin-6659.90% Recom1.00 Target Price40.00
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q16.88% Payout- Rel Volume0.02 Prev Close8.00
Sales Surprise- EPS Surprise- Sales Q/Q-100.00% Earnings- Avg Volume98.14K Price8.13
SMA2018.81% SMA5014.81% SMA200-5.77% Trades Volume1,964 Change1.63%
Feb-13-24 07:59AM
Jan-08-24 07:59AM
Jan-02-24 08:35AM
Dec-28-23 05:00PM
Dec-19-23 05:19PM
09:03AM Loading…
Dec-13-23 09:03AM
Dec-11-23 11:18AM
08:01AM
Nov-29-23 04:27PM
07:59AM
Nov-09-23 07:59AM
Sep-14-23 08:30AM
Sep-07-23 04:14PM
Aug-01-23 07:59AM
Jul-31-23 06:00AM
08:43AM Loading…
Jul-20-23 08:43AM
08:40AM
Jul-13-23 09:14AM
Jun-30-23 09:28AM
Jun-29-23 02:50PM
08:29AM
Jun-06-23 04:30PM
Jun-05-23 09:00AM
Jun-01-23 07:57AM
May-14-23 08:13AM
May-03-23 08:26AM
Mar-02-23 08:00AM
Feb-23-23 08:00AM
Feb-16-23 07:30AM
Jan-18-23 08:00AM
05:18PM Loading…
Dec-14-22 05:18PM
Dec-12-22 07:00AM
Dec-07-22 04:00PM
Dec-06-22 08:00AM
Nov-28-22 07:05PM
Nov-22-22 04:00PM
Oct-27-22 09:50AM
Oct-17-22 08:00AM
Oct-14-22 09:48AM
Oct-13-22 04:00PM
Oct-12-22 08:00AM
07:31AM
Oct-10-22 09:39AM
Oct-03-22 06:03PM
09:09AM
Sep-28-22 09:00AM
Sep-20-22 08:00AM
Sep-15-22 08:00AM
Sep-12-22 11:53AM
Sep-09-22 10:32AM
Sep-06-22 09:30AM
Aug-24-22 08:00AM
Aug-18-22 08:00AM
Aug-11-22 08:00AM
07:30AM
Aug-05-22 09:00AM
Aug-02-22 07:00AM
Jul-14-22 08:00AM
Jun-23-22 09:00AM
08:00AM
Jun-22-22 08:00AM
07:30AM
Apr-14-22 04:15PM
Apr-05-22 03:57PM
Mar-30-22 04:15PM
Mar-08-22 08:00AM
07:30AM
Feb-24-22 08:00AM
Feb-09-22 08:00AM
Feb-03-22 08:00AM
Jan-26-22 08:00AM
Dec-23-21 11:35AM
07:36AM
Dec-21-21 08:00AM
Dec-01-21 08:00AM
Nov-29-21 05:45PM
Nov-24-21 08:52AM
07:34AM
Nov-23-21 11:39AM
11:31AM
08:00AM
05:02AM
Nov-17-21 08:00AM
07:30AM
Nov-11-21 08:00AM
Nov-09-21 08:00AM
Oct-27-21 11:40AM
07:45AM
07:15AM
Oct-18-21 01:37PM
11:07AM
Oct-14-21 09:13AM
07:15AM
Oct-11-21 10:08AM
08:20AM
Oct-05-21 08:37AM
Oct-04-21 08:00AM
Sep-29-21 04:30PM
Sep-20-21 12:51PM
Sep-17-21 04:05PM
Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STEINMAN LAWRENCEDirectorJun 02Buy0.4330,00012,9301,327,174Jun 06 09:00 PM